Ignite Creation Date:
2024-07-17 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06499025
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-07-07
Brief Title:
Treatment of Relapsed or Refractory t8 21 AML With Targeted AML1-ETO Neoantigen Cytotoxic T Cells CTL
Sponsor:
BGI China
Organization:
BGI China
Conditions & Keywords Data
Conditions:
| Name |
|---|
| AML |
| t821 |
| Neoantigen |
Keywords: